ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2205

Presence of Nailfold Capillary Changes Correlates with More Severe Organ Involvement in Juvenile Systemic Scleroderma. Results of the Juvenile Scleroderma Inception Cohort

Ivan Foeldvari1, Jens Klotsche2, Kathryn Torok3, Ozgur Kasapcopur4, Amra Adrovic5, Brian Feldman6, Jordi Anton7, Sindhu R. Johnson8, Flavio Sztajnbok9, Maria Teresa Terreri10, Ana Sakamoto11, Valda Stanevica12, Dieneke Schonenberg-Meinema13, Ekaterina Alexeeva14, Maria Katsicas15, Raju Khubchandani16, Sujata Sawhney17, vanessa smith18, Eslam Al-Abadi19, Simone Appenzeller20, Tadey Avcin21, Mikhail Kostik22, Thomas Lehman23, Hana Malcova24, edoardo marrani25, Clare Pain26, Anjali Patwardhan27, Walter Alberto Sifuentes-Giraldo28, Natalia Vasquez-Canizares29, Sima Abu Alsaoud30, Patricia Costa Reis31, Mahesh Janarthanan32, Dana Nemcova33, Maria Jose Santos34 and Nicola Helmus35, 1Hamburger Zentrum für Kinder- und Jugendrheumatologie, Hamburg, Germany, 2German Rheumatism Research Center, Berlin, Germany, 3Division of Rheumatology, Scleroderma Center, Department of Pediatrics, UPMC Children’s Hospital of Pittsburgh, Pittsburgh, PA, USA, Pittsburgh, PA, 4Istanbul University-Cerrahpasa, Cerrahpasa Medical School, istanbul, Turkey, 5Cerrahpasa Medical School, Istanbul, Turkey, 6Division of Rheumatology, The Hospital for Sick Children; Departments of Pediatrics and Medicine, Faculty of Medicine; The Institute for Health Policy, Management and Evaluation, Dalla Lana School of Public Health, University of Toronto, Toronto, ON, Canada, 7Hospital Sant Joan de Déu. Universitat de Barcelona, Esplugues de Llobregat (Barcelona), Spain, 8University of Toronto, Toronto, Canada, 9UFRJ/UERJ, SAO PAULO, Brazil, 10UNIFESP, São Paulo, SP, Brazil, 11Federal University of São Paulo (UNIFESP), São Paulo, SP, Brazil, 12Childrens Clinical University Hospital, Zemgales priekšpilseta, Riga, Latvia, 13Emma Children’s Hospital, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, Netherlands, 14National Medical Research Center of Children's Health, Sechenov First Moscow State Medical University of the Ministry of Health of the Russian Federation, Moscow, Russia, 15Hospital Garrahan, Buenos Aires, Argentina, 16SRCC Childrens Hospital, Mumbai, India, 17Sir Ganga Ram Hospital, Sector 37 noida, Uttar Pradesh, India, 18Ghent University Hospital, Gent, Belgium, 19Birmingham Women’s and Children’s Hospital NHSFT, Birmingham, United Kingdom, 20Unicamp, Campinas, SP, Brazil, 21University Children's Hospital University Medical Center Ljubljana, Ljubljana, Slovenia, 22Saint-Petersburg State Pediatric Medical University, Saint Petersburg, Russia, 23Hospital for Special Surgery, New York, NY, 24Motol University Hospital, Prague, Czech Republic, 25Dipartimento Neurofarba, Università di Firenze, Firenze, Italy, 26Alderhey Children's NHS Foundation Trust, Liverpool, United Kingdom, 27University of Missouri-Columbia, Department of Child Health, 404 N Keene Street, Columbia MO 65210, Columbia, 28Hospital Universitario Ramon y Cajal, Madrid, Spain, 29Children’s Hospital at Montefiore, Bronx, NY, 30Caritas baby Hospital, East Jerusalem, Israel, 31Hospital de Santa Maria, Lisbon, Portugal, 32SRI RAMACHANDRA INSTITUTE OF HIGHER EDUCATION AND RESEARCH, Chennai, Tamil Nadu, India, 33MD, Prague, Czech Republic, 34Hospital Garcia de Orta and Centro Académico de Medicina de Lisboa, Lisboa, Portugal, 35Hamburg Centre for Pediatric and Adolescence Rheumatology, Hamburg, Germany

Meeting: ACR Convergence 2024

Keywords: Pediatric rheumatology, Systemic sclerosis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, November 18, 2024

Title: Pediatric Rheumatology – Clinical Poster III

Session Type: Poster Session C

Session Time: 10:30AM-12:30PM

Background/Purpose: Juvenile systemic scleroderma (jSSc) is an orphan disease with a prevalence in 3 in 1 000 000 children. Positive nailfold capillaroscopy (NF+) finding correlate with more severe disease in adult systemic scleroderma [1]. There is currently no data if this correlation does exist in jSSc.

Methods: Baseline data was extracted from patients enrolled in the juvenile scleroderma inception cohort that had nailfold capillaroscopy performed at inclusion [2] until 1st of December 2023. NF was performed by dermatoscope and/or high resolution video nailfold capillaroscopy. We compared patients with NF+ and NF- findings from the baseline visit using chi-square test.

Results: 237 patients were included in the analysis, 185 (78%) of them were female. 126 (70%) had diffuse subtype. 183/237 patients (77%) were in the NF+ group. 71% in the NF+ group were Caucasian compared to 85% in the NF- group (p=0.051). Median disease duration was 2.3 years in the NF+ and 3.2 years in the NF- patients. Median age at onset of the first non-Raynaud´s was around 11 years in both groups. More patients in the NF+ group were ANA positive (95% compared to 79%, p< 0.001). There was no difference in the anti-Scl70 or anti-centromere distribution.
NF+ patients had significantly more frequent Raynaud phenomenon (96% compared to 78%, p< 0.001); history of digital ulcerations (59% compared to 27%, p< 0.001); abnormal high resolution CT findings of the lung (49% compared to 30%, p=0.034); overall gastrointestinal involvement (49% compared to 20%, p< 0.001); oesophageal involvement (47% compared to 19%, p< 0.001); musculoskeletal involvement (71% compared to 41%, p=0.003); presence of joints with decreased range (63% versus 45%, p=0.022) and presence of muscle weakness (25% compared to 3%, p=0.002). No significant differences were demonstrated in involvement of other organ systems such as skin, cardiac or renal. (see table 1)
 

Conclusion: In a jSSc cohort there were significantly more patients affected within various organ systems in those with nailfold capillary changes at enrollment compared to those without. Future studies should assess whether these differences persist over time.

[1]       Vanhaecke A, Cutolo M, Distler O, et al. Nailfold capillaroscopy in SSc: innocent bystander or promising biomarker for novel severe organ involvement/progression? Rheumatology (Oxford). 2022 Nov 2;61(11):4384-4396.

[2]       Foeldvari I, Klotsche J, Kasapcopur O, et al. Differences Sustained Between Diffuse and Limited Forms of Juvenile Systemic Sclerosis in an Expanded International Cohort. Arthritis Care Res (Hoboken). 2022 Oct;74(10):1575-1584.

Supporting image 1

Table 1


Disclosures: I. Foeldvari: Boehringer-Ingelheim, 1, Eli Lilly, 6, miirsubishi, 2; J. Klotsche: None; K. Torok: None; O. Kasapcopur: None; A. Adrovic: None; B. Feldman: None; J. Anton: None; S. Johnson: None; F. Sztajnbok: None; M. Terreri: None; A. Sakamoto: None; V. Stanevica: None; D. Schonenberg-Meinema: None; E. Alexeeva: Johnson & Johnson, 6, Novartis, 6, Roche, 6; M. Katsicas: None; R. Khubchandani: None; S. Sawhney: None; v. smith: Argenx, 2, BKC Moving Media Makers, 6, Boehringer-Ingelheim, 2, 5, 6, Janssen, 2, 5, 6, WebMDD Global LLC, 2; E. Al-Abadi: None; S. Appenzeller: None; T. Avcin: None; M. Kostik: None; T. Lehman: None; H. Malcova: None; e. marrani: None; C. Pain: None; A. Patwardhan: None; W. Sifuentes-Giraldo: None; N. Vasquez-Canizares: Boehringer-Ingelheim, 2; S. Abu Alsaoud: None; P. Costa Reis: None; M. Janarthanan: None; D. Nemcova: None; M. Santos: None; N. Helmus: None.

To cite this abstract in AMA style:

Foeldvari I, Klotsche J, Torok K, Kasapcopur O, Adrovic A, Feldman B, Anton J, Johnson S, Sztajnbok F, Terreri M, Sakamoto A, Stanevica V, Schonenberg-Meinema D, Alexeeva E, Katsicas M, Khubchandani R, Sawhney S, smith v, Al-Abadi E, Appenzeller S, Avcin T, Kostik M, Lehman T, Malcova H, marrani e, Pain C, Patwardhan A, Sifuentes-Giraldo W, Vasquez-Canizares N, Abu Alsaoud S, Costa Reis P, Janarthanan M, Nemcova D, Santos M, Helmus N. Presence of Nailfold Capillary Changes Correlates with More Severe Organ Involvement in Juvenile Systemic Scleroderma. Results of the Juvenile Scleroderma Inception Cohort [abstract]. Arthritis Rheumatol. 2024; 76 (suppl 9). https://acrabstracts.org/abstract/presence-of-nailfold-capillary-changes-correlates-with-more-severe-organ-involvement-in-juvenile-systemic-scleroderma-results-of-the-juvenile-scleroderma-inception-cohort/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2024

ACR Meeting Abstracts - https://acrabstracts.org/abstract/presence-of-nailfold-capillary-changes-correlates-with-more-severe-organ-involvement-in-juvenile-systemic-scleroderma-results-of-the-juvenile-scleroderma-inception-cohort/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology